Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 192

1.

A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology.

Alosco ML, Sugarman MA, Besser LM, Tripodis Y, Martin B, Palmisano JN, Kowall NW, Au R, Mez J, DeCarli C, Stein TD, McKee AC, Killiany RJ, Stern RA.

J Alzheimers Dis. 2018;63(4):1347-1360. doi: 10.3233/JAD-180017.

PMID:
29843242
2.

Assessment of the Mid-Life Demographic and Lifestyle Risk Factors of Dementia Using Data from the Framingham Heart Study Offspring Cohort.

Li J, Ogrodnik M, Kolachalama VB, Lin H, Au R.

J Alzheimers Dis. 2018;63(3):1119-1127. doi: 10.3233/JAD-170917.

PMID:
29710704
3.

Word-list intrusion errors predict progression to mild cognitive impairment.

Thomas KR, Eppig J, Edmonds EC, Jacobs DM, Libon DJ, Au R, Salmon DP, Bondi MW; Alzheimer’s Disease Neuroimaging Initiative*.

Neuropsychology. 2018 Feb;32(2):235-245. doi: 10.1037/neu0000413.

PMID:
29528684
4.

Pramlintide: The Effects of a Single Drug Injection on Blood Phosphatidylcholine Profile for Alzheimer's Disease.

Tao Q, Zhu H, Chen X, Stern RA, Kowall N, Au R, Blusztajn JK, Qiu WQ; Alzheimer’s Disease Metabolomics Consortium.

J Alzheimers Dis. 2018;62(2):597-609. doi: 10.3233/JAD-170948.

5.

How technology is reshaping cognitive assessment: Lessons from the Framingham Heart Study.

Au R, Piers RJ, Devine S.

Neuropsychology. 2017 Nov;31(8):846-861. doi: 10.1037/neu0000411.

PMID:
29376667
6.

Assessing Working Memory in Mild Cognitive Impairment with Serial Order Recall.

Emrani S, Libon DJ, Lamar M, Price CC, Jefferson AL, Gifford KA, Hohman TJ, Nation DA, Delano-Wood L, Jak A, Bangen KJ, Bondi MW, Brickman AM, Manly J, Swenson R, Au R; Consortium for Clinical and Epidemiological Neuropsychological Data Analysis (CENDA).

J Alzheimers Dis. 2018;61(3):917-928. doi: 10.3233/JAD-170555.

7.

White matter signal abnormalities in former National Football League players.

Alosco ML, Koerte IK, Tripodis Y, Mariani M, Chua AS, Jarnagin J, Rahimpour Y, Puzo C, Healy RC, Martin B, Chaisson CE, Cantu RC, Au R, McClean M, McKee AC, Lin AP, Shenton ME, Killiany RJ, Stern RA.

Alzheimers Dement (Amst). 2017 Nov 6;10:56-65. doi: 10.1016/j.dadm.2017.10.003. eCollection 2018.

8.

Barriers to medication adherence and links to cardiovascular disease risk factor control: the Framingham Heart Study.

Hennein R, Hwang SJ, Au R, Levy D, Muntner P, Fox CS, Ma J.

Intern Med J. 2018 Apr;48(4):414-421. doi: 10.1111/imj.13687.

PMID:
29193523
9.

Data Platform for the Research and Prevention of Alzheimer's Disease.

An N, Jin L, Yang J, Yin Y, Jiang S, Jing B, Au R.

Adv Exp Med Biol. 2017;1028:55-78. doi: 10.1007/978-981-10-6041-0_4. Review.

PMID:
29058216
10.

Progress toward standardized diagnosis of vascular cognitive impairment: Guidelines from the Vascular Impairment of Cognition Classification Consensus Study.

Skrobot OA, Black SE, Chen C, DeCarli C, Erkinjuntti T, Ford GA, Kalaria RN, O'Brien J, Pantoni L, Pasquier F, Roman GC, Wallin A, Sachdev P, Skoog I; VICCCS group, Ben-Shlomo Y, Passmore AP, Love S, Kehoe PG.

Alzheimers Dement. 2018 Mar;14(3):280-292. doi: 10.1016/j.jalz.2017.09.007. Epub 2017 Oct 19.

PMID:
29055812
11.

Age and Graphomotor Decision Making Assessed with the Digital Clock Drawing Test: The Framingham Heart Study.

Piers RJ, Devlin KN, Ning B, Liu Y, Wasserman B, Massaro JM, Lamar M, Price CC, Swenson R, Davis R, Penney DL, Au R, Libon DJ.

J Alzheimers Dis. 2017;60(4):1611-1620. doi: 10.3233/JAD-170444.

PMID:
29036819
12.

Baseline White Matter Hyperintensities and Hippocampal Volume are Associated With Conversion From Normal Cognition to Mild Cognitive Impairment in the Framingham Offspring Study.

Bangen KJ, Preis SR, Delano-Wood L, Wolf PA, Libon DJ, Bondi MW, Au R, DeCarli C, Brickman AM.

Alzheimer Dis Assoc Disord. 2018 Jan-Mar;32(1):50-56. doi: 10.1097/WAD.0000000000000215.

PMID:
28984639
13.

CCL11 is increased in the CNS in chronic traumatic encephalopathy but not in Alzheimer's disease.

Cherry JD, Stein TD, Tripodis Y, Alvarez VE, Huber BR, Au R, Kiernan PT, Daneshvar DH, Mez J, Solomon TM, Alosco ML, McKee AC.

PLoS One. 2017 Sep 26;12(9):e0185541. doi: 10.1371/journal.pone.0185541. eCollection 2017.

14.

Atrial fibrillation and cognitive decline in the Framingham Heart Study.

Nishtala A, Piers RJ, Himali JJ, Beiser AS, Davis-Plourde KL, Saczynski JS, McManus DD, Benjamin EJ, Au R.

Heart Rhythm. 2018 Feb;15(2):166-172. doi: 10.1016/j.hrthm.2017.09.036. Epub 2017 Sep 22.

PMID:
28943482
15.

Biometric monitoring devices for assessing end points in clinical trials: developing an ecosystem.

Arnerić SP, Cedarbaum JM, Khozin S, Papapetropoulos S, Hill DL, Ropacki M, Rhodes J, Dacks PA, Hudson LD, Gordon MF, Kern VD, Romero K, Vradenburg G, Au R, Karlin DR, Facheris MF, Fitzer-Attas CJ, Vitolo OV, Wang J, Miller BM, Kaye JA.

Nat Rev Drug Discov. 2017 Oct;16(10):736. doi: 10.1038/nrd.2017.153. Epub 2017 Sep 22. No abstract available.

PMID:
28935908
16.

Age of first exposure to American football and long-term neuropsychiatric and cognitive outcomes.

Alosco ML, Kasimis AB, Stamm JM, Chua AS, Baugh CM, Daneshvar DH, Robbins CA, Mariani M, Hayden J, Conneely S, Au R, Torres A, McClean MD, McKee AC, Cantu RC, Mez J, Nowinski CJ, Martin BM, Chaisson CE, Tripodis Y, Stern RA.

Transl Psychiatry. 2017 Sep 19;7(9):e1236. doi: 10.1038/tp.2017.197.

17.

Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease: A Meta-analysis.

Neu SC, Pa J, Kukull W, Beekly D, Kuzma A, Gangadharan P, Wang LS, Romero K, Arneric SP, Redolfi A, Orlandi D, Frisoni GB, Au R, Devine S, Auerbach S, Espinosa A, Boada M, Ruiz A, Johnson SC, Koscik R, Wang JJ, Hsu WC, Chen YL, Toga AW.

JAMA Neurol. 2017 Oct 1;74(10):1178-1189. doi: 10.1001/jamaneurol.2017.2188.

PMID:
28846757
18.

Cognitive performance norms from the Korean genome and epidemiology study (KoGES).

Kim H, Au R, Thomas RJ, Yun CH, Lee SK, Han C, Shin C.

Int Psychogeriatr. 2017 Nov;29(11):1909-1924. doi: 10.1017/S1041610217000990. Epub 2017 Jul 13.

PMID:
28703093
19.

Practical risk score for 5-, 10-, and 20-year prediction of dementia in elderly persons: Framingham Heart Study.

Li J, Ogrodnik M, Devine S, Auerbach S, Wolf PA, Au R.

Alzheimers Dement. 2018 Jan;14(1):35-42. doi: 10.1016/j.jalz.2017.04.013. Epub 2017 Jun 13.

PMID:
28627378
20.

Amyloid Burden in Obstructive Sleep Apnea.

Yun CH, Lee HY, Lee SK, Kim H, Seo HS, Bang SA, Kim SE, Greve DN, Au R, Shin C, Thomas RJ.

J Alzheimers Dis. 2017;59(1):21-29. doi: 10.3233/JAD-161047.

PMID:
28550245

Supplemental Content

Loading ...
Support Center